Incontinence-associated dermatitis, skin breakdown resulting from prolonged moisture and irritant exposure in incontinent patients, remains a common complication that receives less dedicated prevention attention than pressure injuries despite meaningful overlap in the affected patient population and real quality-of-life and, in more severe cases, wound care cost implications.
Building a Risk-Matched Prevention Approach
- Barrier creams and ointments for standard risk patients, providing a protective layer between skin and moisture without requiring frequent reapplication that would burden already stretched nursing staff time
- More durable barrier film products for higher-risk patients with more frequent incontinence episodes or already-compromised skin integrity, offering longer-lasting protection between changes
- Appropriate absorbent product selection matched to actual output volume, since an undersized absorbent product leading to more frequent leakage and skin moisture exposure undermines barrier product effectiveness regardless of how well the barrier itself is applied
Why Consistency Matters More Than Product Choice Alone
Even well-selected barrier products only prevent dermatitis if applied consistently at every incontinence care episode — a protocol compliance challenge similar to other supply-dependent prevention practices, where product availability at the point of care directly affects whether staff actually follow the intended protocol under real workload pressure.
The Business Case
Facilities with formal incontinence-associated dermatitis prevention programs, including consistent barrier product use, report measurably lower dermatitis incidence than facilities without a structured approach — a difference that matters both for resident comfort and for facilities in settings where skin integrity metrics factor into quality reporting.
Facilities building skin protection programs can review Healix Medical Supply's skin care catalog.
